MLchartDataset catalogue

MAGE-12 peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-014963

A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified as an epitope recognized by tumor infiltrating lymphocytes (TIL). Vaccination with MAGE-12 peptide stimulates the host immune system to mount a TIL response against tumor cells expressing MAGE-12, potentially resulting in decreased tumor growth.

Table 1. Record
IdentifierMLC-T-ONC-014963
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014963",
  "term": "MAGE-12 peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified as an epitope recognized by tumor infiltrating lymphocytes (TIL). Vaccination with MAGE-12 peptide stimulates the host immune system to mount a TIL response against tumor cells expressing MAGE-12, potentially resulting in decreased tumor growth.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/mage-12-peptide-vaccine/"
}

Record 10,529 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.